From Germany, German-French Alexandra Depelsenaire is currently a Postdoctoral Research Fellow at the Australian Institute for Bioengineering and Nanotechnology (AIBN) at the University of Queensland. Her current research investigates the physical adjuvantation effect of the Nanopatch and other skin-based vaccine delivery devices by studying the local and systemic cellular and immunological responses. Sandra completed her doctoral studies in 2014 at the AIBN in Biomedical Engineering, in which she studied the cellular damage in skin following immunisation. Her Biological and Nanotechnology skills obtained during her Undergraduate studies in Germany (Diplom Biologie, Ludwigs-Maximilians Universität, Munich, Germany) and Australia (BSc majoring in Forensic Science, Toxicology, Molecular Biology and Honours in Nanotechnology, both Murdoch University, WA) enabled her to work in a multi-disciplinary field, performing cutting edge science. During her time within this group, she has published several papers, a book chapter, attended national and international conferences, and won several prices including the NSW PhD Student Researcher Award for Excellence in Nanomedicine Research.
Sandra is a very passionate supporter of women in science and technology (WiT) as well as Early Career Researchers (ECR), and sits on multiple executive committees representing these (AIBN ECR, UQ ECR). She has also extensive experience as conference chair co-chair, and ECR-chair of numerous student, national and a few international conferences (ICBNI, NanoBio).
- Novel vaccine candidates
- Skin-based immunisation
- Physical adjuvantation